Wandercraft Raises 75 Million to Advance AI-Powered Robotics

Wandercraft, a pioneer in self-balancing robotic mobility systems, has secured a substantial $75 million in Series D funding to accelerate the development and commercialization of AI-powered robotics. This funding round features major contributions from industry leaders such as Renault Group, Bpifrance, the European Investment Bank, Teampact Ventures, and Quadrant Management. The capital injection arrives at a pivotal moment as Wandercraft expands its global footprint and innovates across clinical, consumer, and industrial robotics sectors.

At the heart of Wandercraft’s next growth phase is the launch of Eve, the world’s first self-balancing personal exoskeleton, anticipated to hit the market by 2026. Alongside Eve, the company is scaling clinical adoption of its flagship rehabilitation robot, Atalante X, and advancing the development and deployment of Calvin-40, a humanoid robot designed for industrial applications. These innovations promise to transform mobility and labor across rehabilitation centers, home environments, and factory floors.

A landmark partnership with Renault Group, which now holds a minority stake in Wandercraft, is a cornerstone of this funding round. Renault’s industrial expertise will enable scalable production of Wandercraft’s exoskeletons and humanoid robots. Calvin-40, developed in just 40 days and slated for deployment within 40 weeks at Renault factories, exemplifies this collaboration’s speed and efficiency. Leveraging NVIDIA’s advanced AI platforms, including the Visual Language Model and Jetson AI computing, Calvin-40 represents the first humanoid robot developed by a European company, designed to tackle physically demanding tasks.

Wandercraft’s AI-driven technology is not just innovative but clinically validated. The Atalante X rehabilitation exoskeleton has received FDA clearance for stroke rehabilitation and is deployed in over 100 hospitals worldwide. Clinical trials demonstrate significant improvements in walking speed, balance, independence, and muscle strength for users, alongside reductions in pain and spasticity. The company’s personal exoskeleton, Eve, is undergoing the world’s first clinical trial for hands-free walking at home, aiming to restore mobility for individuals with severe impairments.

Wandercraft’s commitment to accessibility is exemplified by the opening of “Walk in New York by Wandercraft,” the first center offering regular exoskeleton walking sessions for people with mobility disabilities. This facility serves as a regional hub for Eve’s upcoming U.S. launch and is part of a broader strategy to expand rehabilitation access globally.

The company’s rapid growth is fueled by a robust portfolio of over 30 patents and a proven track record of innovation, including the world’s first self-balancing walking exoskeleton. Wandercraft’s technology has enabled more than 2,500 individuals with mobility disabilities to take over 14 million steps, redefining the possibilities of upright movement without crutches or walkers.

Wandercraft’s recent showcases at global events like the 2024 Olympic and Paralympic Torch Relay and Nvidia’s CES 2025 and GTC conferences highlight its leadership in integrating AI and robotics. Nvidia’s recognition of Wandercraft’s use of physical AI and autonomous walking technology underscores the company’s cutting-edge approach.

Looking ahead, Wandercraft’s Series D funding will accelerate the commercial deployment of Eve in home and outdoor settings, support further growth of Atalante X in clinical environments, and expand the industrial rollout of Calvin-40 and the broader Calvin humanoid family. This trajectory positions Wandercraft at the forefront of AI-powered robotics, transforming how people live, move, and work.

For individuals interested in participating in clinical trials for Eve, Wandercraft invites adults with motor spinal cord injuries to apply, emphasizing real-world usability and integration into daily life. The company is also actively hiring, continuing its mission to restore mobility through AI-powered, self-balancing robotic systems.